ENFUVIRTIDE (FUZEON)

Course overview

Enfuvirtide is an HIV fusion inhibitor that is U.S. FDA-approved to be used in combination with other antiretroviral agents to treat HIV-1 infection in previously treated patients ≥ 6 years with evidence of continued HIV-1 replication despite ongoing antiretroviral therapy. This continuing education module is designed to give the reader/learner an increased understanding of enfuvirtide. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.